EU pharma changes bring new responsibilities - and some confusion
30 November 2009
Ian Schofield
It's been all change in the EU this month, most of it a result of the Lisbon Treaty: a new president of the European Council, a new position of high representative for foreign affairs and security, and now a new-look
European Commission with a range of novel portfolios.
Amongst this frenzy of...
Please Login to read the full article.
30 November 2009
Ian Schofield
Amongst this frenzy of...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Weaker private equity in India for 2012, portfolios turning 'a la carte'
- BIO's policy agenda, UK's Blair featured highlights at 2011 biotech conference
- Portola ready to go it alone after Merck bows out of factor Xa partnership
- Hasegawa a high profile champion for the industry at Davos
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
